By: Upadhyay, Moseley, Lin, Feliciano, Pinaki, Dede, Gary M., Rezvani, Jeong-Min, Shpall, Alexander, Uprety, Katayoun, Sebastian, Mecit, Mohanty, Park, Hong, Li, Yu-Sung, Biederstädt, Marin, Fan, Tobias, Rafet, Ken, Fang, Corry Mathew, Bijender, Kumar, Huihui, Ranjan, Bopp, Jiang, Basar, Moore, Jin, Zhang, Wan, Nadima, Jones, Francia, Xin Ru, Paul, Rejeena, Madison, Yukun, Liu, Gilbert, Toszka, Ye, Sunil, David, Tan, Shanley, Rawal, Shen, Elizabeth J., Shrestha, Kaplan, Sadie Mae, Banerjee, Jain, Ping, April Lamour, Ryan Z., Pinghua, Vakul, Xiong, Yang, Fowlkes, Dou, Nunez Cortes, Bin, Pravin, Chen, Daher, Seema, Deqiang, Hsu, Anirban, Bohn, Muniz, Vernikka, Liang, Phadatare
The transcription factor CREM is a pivotal regulator of NK cell function, making CREM a valuable target to increase the efficacy of anticancer immunotherapies based on this cell population and chimeric antigen receptors.










